CRC Credit Research Compendium
Menu
日本語English

Issuer Credit Research

Issuer Flash: China Modern Dairy Holdings Ltd.

Issuer: China Modern Dairy Holdings | Document: Issuer Flash | Date: 2026-08-28 | Event: 1h2026 Interim Results

Report date: 2026-08-28 Event date: 2026-08-25 Event title: 1H2026 Interim Results

1. Flash Conclusion

China Modern Dairy Holdings Ltd. ("Modern Dairy" or "CMD") reported a material recovery from the prior-year interim loss: revenue rose 8.6% year on year to RMB6.593bn, Cash EBITDA increased 8.3% to RMB1.599bn, and operating cash flow increased 56.8% to RMB768.5m. The group returned to a modest RMB41.7m profit for the period, compared with a RMB983.8m loss in 1H2025. For holders of CMD's U.S.$350m 4.875% bonds due 2030, the result is credit-positive because operating cash generation, near-term working-capital pressure and leverage metrics improved while the U.S.$500m July 2026 maturity was repaid after period end.

The improvement should nevertheless be read as a recovery from an exceptionally weak comparable period, not as proof that the raw-milk cycle has normalised. Raw-milk sales volume and cost discipline offset another decline in average selling price (ASP), and the reported profit still benefited substantially from a smaller loss on the fair-value measurement of dairy cows. Net gearing fell, but remained 108.0% at 30 June 2026 and net borrowings were RMB11.128bn. The July unconditionality and August offer-close disclosures for China Shengmu Organic Milk Limited (CSM) add strategic organic-milk exposure, but their final cash, financing and post-acquisition leverage effects are not established in the interim announcement.

2. 1H2026 Results: Cash and Earnings Recovery

The main change from 1H2025 was the combination of higher volume, lower unit costs and a much smaller biological-asset valuation loss. Raw-milk revenue increased 6.5% to RMB5.399bn as volume rose 8.9% to 1.680m tonnes, despite ASP falling 2.4% to RMB3.21/kg. The integrated dairy farming solutions business contributed further top-line growth, with revenue up 19.0% to RMB1.194bn. Group gross profit increased to RMB1.727bn from RMB1.604bn, although group gross margin was broadly stable at 26.2%.

RMBm unless stated 1H2026 1H2025 Credit reading
Revenue 6,592.8 6,072.5 Higher milk volume and solutions revenue offset lower milk ASP.
Cash EBITDA 1,598.8 1,476.5 Cash earnings improved, but the measure adds back biological-asset fair-value loss and other items.
Operating cash flow 768.5 490.0 Better operating cash conversion supports liquidity.
Profit/(loss) for the period 41.7 (983.8) Turnaround was driven in material part by the smaller dairy-cow fair-value loss.
Dairy-cow fair-value loss (760.1) (1,822.9) Reduced valuation pressure, not an elimination of biological-asset sensitivity.
Net gearing 108.0% n.a. Down from 115.7% at 31 December 2025, but still high.

The fair-value loss on dairy cows fell 58.3% year on year to RMB760.1m. The company attributes the decline to completion of much of its prior-year strategic culling, fewer cattle culled and higher culling prices. This reduction, together with higher gross profit, was central to the return to profit. It is an improvement in the earnings drag from herd valuation, but does not make the underlying exposure irrelevant: raw-milk economics and dairy-cow values remain material to equity protection and reported earnings.

Operationally, the group increased milkable cows as a proportion of its herd to 60.1% from 54.1% a year earlier, while total herd size declined 2.5% to 460,854 head. Average annualised milk yield improved slightly to 13.3 tonnes per milkable cow. Lower feed prices supported average raw-milk unit cost before inter-segment offset of RMB2.29/kg, versus RMB2.32/kg in 1H2025. These metrics demonstrate improved operating efficiency, but ASP remained below the prior-year level; the recovery is therefore volume- and cost-led rather than evidence of restored pricing power.

3. Credit Read-Through: Liquidity and Refinancing Improved, but Leverage Remains Material

Liquidity indicators strengthened at the reporting date. Total equity rose to RMB10.308bn from RMB9.818bn at end-2025, net current liabilities narrowed to RMB26.0m from RMB467.0m, and available undrawn credit facilities increased to RMB7.805bn from RMB7.420bn. Net borrowings declined slightly to RMB11.128bn from RMB11.355bn, reducing net gearing by 7.7 percentage points to 108.0%.

The post-period repayment on 10 July 2026 of the U.S.$500m bonds due 14 July 2026 is an additional positive maturity-management outcome. The interim filing states that the U.S.$350m 4.875% bonds due 2030 remained outstanding; for those bondholders, removal of the nearer U.S.-dollar maturity reduces immediate refinancing pressure. However, finance costs rose 21.0% to RMB353.7m, including a 27.0% increase in interest-bearing-borrowing costs, which the company attributes to a larger borrowing base. The better cash profile and unused facilities mitigate, but do not remove, sensitivity to financing costs, raw-milk pricing and biological-asset values.

The balance-sheet assessment also needs to distinguish unrestricted liquidity from amounts presented as restricted deposits. Current restricted bank deposits were RMB1.842bn at 30 June, versus RMB8.3m at end-2025. The report does not provide sufficient detail in the results announcement to determine their availability for general debt service. The group states that its expected operating cash inflows and facilities should meet obligations as they fall due, but this is management's going-concern assessment rather than independent confirmation of post-period funding capacity.

For the 2030 bonds, the near-term refinancing result is therefore helpful but not sufficient on its own to establish a conservative liquidity buffer. The reduction in net current liabilities and repayment of the July maturity reduce immediate pressure, while the increase in operating cash flow provides a more relevant recurring source of debt-service capacity than the accounting profit alone. Offsetting that support, the group continued to carry net borrowings exceeding total equity, incurred higher finance costs, and had a material balance of deposits explicitly classified as restricted. The next results should show whether post-maturity cash deployment, facility usage and CSM-related funding preserve the improvement in gearing rather than merely shifting funding needs into a later period.

4. CSM Acquisition: Strategic Expansion, Financial Follow-Through Pending

CMD's CSM acquisition has moved from the conditional status described in the May issuer summary to an executed ownership event. The 20 July joint announcement stated that the mandatory conditional offer had become unconditional in all respects. The 3 August revised closing announcement reported CMD's direct holding at 53.53% of CSM shares and CMD plus concert parties at 83.52%. CMD describes CSM as providing access to desert-sourced organic milk and expanding its higher-end raw-milk supply.

The strategic rationale may strengthen product mix and farming scale, but this flash does not treat the transaction as a demonstrated financial benefit. The 1H2026 balance sheet predates the offer closing, and the interim announcement does not quantify final offer cash payments, the post-closing funding structure, purchase accounting or pro forma leverage. These items are important for the 2030 bondholders because the pre-acquisition leverage level remains high. They should be confirmed from subsequent CSM/CMD filings and the next consolidated financial results rather than inferred from the announced shareholding percentages.

5. What To Watch Next

6. Sources